Events Calendar
In This Section
Hospital connects to patients online
Study finds breast cancer overtreated
Monkeys live longer on low-cal diet; would humans?
British scientists claim to create human sperm from stem cells
White House, hospitals reach deal on health care
Maryland doctor says kidney transplant record achieved
Final rules out for government stem cell research
Most Read Stories
Akron police investigate teen mob attack on family
Man found hanging at playground in Stow
Relatives doubt story of suicide
FBI asked to investigate attack on white family near Firestone Park
Man shot in back near Akron park
Robbery suspect's body left at Akron hospital
Blogs:
Pets:
Zeke, the basketball playing dog
The Heldenfiles:
Friday Notebook
Patrick McManamon:
For your Saturday entertainment …
Akron Zips:
Six new scholarship offers
Browns Bulletin:
Quick thought on Browns rookies
Tribe Matters:
Tribe roster on hold?
Cleveland Browns:
Stallworth test showed marijuana
Kent State Sports:
Men's Basketball Scheduling update
Cleveland Cavaliers:
Andy’s Signed According to ESPN
All Da King's Men:
Our Radical New Science Czar
Blog of Mass Destruction:
Overwhelming Evidence
Akron Law Café:
New Wiretapping Revelations from Inspector General
Varsity Letters:
Report: Ontko selects Wisconsin
See Jane Style:
Oh Baby!
Car Chase:
Where do We Go from Here?
Let's Talk Real Estate:
Closings….Not the Good Kind!
Ohio Travels with Betty:
Margy inquires-when is a Taste of Hudson?
Sound Check:
LeVert II live performance Saturday night — "Dedication" album due July 13,
HRLite House:
DDI One of Best Places to Work
Akron Gamer:
Video game sales drop in May
FDA reports show blood thinner, anti-smoking drug account for large share
Published on Thursday, Oct 23, 2008
WASHINGTON: The number of serious drug reactions and deaths reported to the government shot up in the first three months of the year to set a record, a health industry watchdog group said Wednesday.
The Food and Drug Administration received nearly 21,000 reports of serious drug reactions, including more than 4,800 deaths, according to an analysis of federal data by the Institute for Safe Medication Practices.
Two drugs accounted for a large share of the latest reports. One was heparin, the tainted blood thinner from China that caused an international safety scandal. The other was Chantix, a new kind of anti-smoking drug from Pfizer.
Chantix, which had the most reports of any medication, works directly in a smoker's brain to ease withdrawal symptoms. It also blocks the pleasurable effects of nicotine if the patient is tempted to light up again. Earlier this year, the FDA warned that Chantix may be linked to psychiatric problems, including suicidal behavior and vivid dreams. Pfizer said Wednesday it stands by Chantix, and that the volume of reports might be linked to publicity about the side effects.
''The FDA is aware of the increasing number of reports, and we take them seriously,'' said spokesman Christopher DiFrancesco. But officials are not sure whether reports are up because problems are getting worse, or simply because of greater awareness of drug safety issues.
The watchdog group that prepared the analysis has served hospitals and pharmacists for years as a clearinghouse for information on medication errors. The ISMP is now trying to reach consumers with regular reports on drug safety trends.
''We believe that one of the most important tools to promote is to monitor trends on a regular basis,'' said Thomas J. Moore, a scientist with the ISMP. ''Knowing which drugs are causing injuries and how many people are being hurt is the raw material we need to fashion sound measures to promote patient safety.''
The FDA defines serious drug reactions as ones that cause hospitalization, require medical intervention, or place a life in jeopardy. The agency's monitoring system relies on voluntary reports from doctors and is only believed to capture a fraction of overall problems.
The 20,745 cases reported from January through March was 38 percent higher than the average for the previous four calendar quarters, and the highest for any quarter, the report said. The number of deaths, 4,824, was a nearly threefold increase from the last calendar quarter of 2007. The FDA said heparin was largely to blame.
Previous ISMP research has shown that reports of serious drug-safety problems had increased markedly since the late 1990s.
The FDA case reports provide a signal of possible problems with a drug, but a cause-and-effect connection only can be established through painstaking investigation.
WASHINGTON: The number of serious drug reactions and deaths reported to the government shot up in the first three months of the year to set a record, a health industry watchdog group said Wednesday.
Get the full article here.
Comments
Click here to post your comments
